Caraballo R S, Giovino G A, Pechacek T F, Mowery P D, Richter P A, Strauss W J, Sharp D J, Eriksen M P, Pirkle J L, Maurer K R
National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30341-3724, USA.
JAMA. 1998 Jul 8;280(2):135-9. doi: 10.1001/jama.280.2.135.
Cotinine, a metabolite of nicotine, is a marker of exposure to tobacco smoke. Previous studies suggest that non-Hispanic blacks have higher levels of serum cotinine than non-Hispanic whites who report similar levels of cigarette smoking.
To investigate differences in levels of serum cotinine in black, white, and Mexican American cigarette smokers in the US adult population.
Third National Health and Nutrition Examination Survey, 1988-1991.
A nationally representative sample of persons aged 17 years or older who participated in the survey.
Serum cotinine levels by reported number of cigarettes smoked per day and by race and ethnicity.
A total of 7182 subjects were involved in the study; 2136 subjects reported smoking at least 1 cigarette in the last 5 days. Black smokers had cotinine concentrations substantially higher at all levels of cigarette smoking than did white or Mexican American smokers (P<.001). Serum cotinine levels for blacks were 125 nmol/L (22 ng/mL) (95% confidence interval [CI], 79-176 nmol/L [14-31 ng/mL]) to 539 nmol/L (95 ng/mL) (95% CI, 289-630 nmol/L [51-111 ng/mL]) higher than for whites and 136 nmol/L (24 ng/mL) (95% CI, 85-182 nmol/L [15-32 ng/mL]) to 641 nmol/L (113 ng/mL) (95% CI, 386-897 nmol/L [68-158 ng/mL]) higher than for Mexican Americans. These differences do not appear to be attributable to differences in environmental tobacco smoke exposure or in number of cigarettes smoked.
To our knowledge, this study provides the first evidence from a national study that serum cotinine levels are higher among black smokers than among white or Mexican American smokers. If higher cotinine levels among blacks indicate higher nicotine intake or differential pharmacokinetics and possibly serve as a marker of higher exposure to cigarette carcinogenic components, they may help explain why blacks find it harder to quit and are more likely to experience higher rates of lung cancer than white smokers.
可替宁是尼古丁的一种代谢产物,是接触烟草烟雾的一个标志物。以往研究表明,报告吸烟量相似的非西班牙裔黑人的血清可替宁水平高于非西班牙裔白人。
调查美国成年人群中黑人、白人和墨西哥裔美国吸烟者的血清可替宁水平差异。
1988 - 1991年第三次全国健康和营养检查调查。
参与该调查的17岁及以上具有全国代表性的人群样本。
根据报告的每日吸烟量以及种族和民族划分的血清可替宁水平。
共有7182名受试者参与该研究;2136名受试者报告在过去5天内至少吸了1支烟。在所有吸烟水平上,黑人吸烟者的可替宁浓度均显著高于白人或墨西哥裔美国吸烟者(P<0.001)。黑人的血清可替宁水平比白人高125纳摩尔/升(22纳克/毫升)(95%置信区间[CI],79 - 176纳摩尔/升[14 - 31纳克/毫升])至539纳摩尔/升(95纳克/毫升)(95%CI,289 - 630纳摩尔/升[51 - 111纳克/毫升]),比墨西哥裔美国人高136纳摩尔/升(24纳克/毫升)(95%CI,85 - 182纳摩尔/升[15 - 32纳克/毫升])至641纳摩尔/升(113纳克/毫升)(95%CI,386 - 897纳摩尔/升[68 - 158纳克/毫升])。这些差异似乎并非归因于环境烟草烟雾暴露或吸烟量的差异。
据我们所知,本研究提供了来自一项全国性研究的首个证据,即黑人吸烟者的血清可替宁水平高于白人或墨西哥裔美国吸烟者。如果黑人中较高的可替宁水平表明较高的尼古丁摄入量或不同的药代动力学,并且可能作为更高接触香烟致癌成分的一个标志物,那么它们可能有助于解释为什么黑人比白人吸烟者更难戒烟且更易患肺癌。